Gardner Expands Compliance and Litigation Capabilities with Addition of Vivian Egbu

May 04, 2026

Gardner Law is pleased to announce that Vivian Egbu has joined the firm, further strengthening our compliance and enforcement capabilities for companies in FDA-regulated industries.

Vivian advises medtech, biotech, pharmaceutical, digital health, and diagnostic companies on healthcare compliance, regulatory risk, enforcement matters, and complex disputes across the product life cycle. She brings prior experience as an Assistant Attorney General, giving clients insight into how regulators and enforcement agencies evaluate risk, conduct investigations, coordinate across agencies, and pursue enforcement strategies.

Vivian’s background is particularly valuable for companies facing issues that sit at the intersection of compliance, enforcement, reimbursement, and litigation. Her experience includes healthcare fraud litigation, whistleblower matters, administrative proceedings, Medicaid and government program enforcement, licensing and sanctions disputes, reimbursement issues, and regulatory enforcement actions.

For Gardner Law clients, Vivian’s arrival expands the firm’s ability to help companies prepare for government scrutiny, respond strategically when issues escalate, and design compliance programs informed by real-world enforcement priorities.

Her experience strengthens Gardner Law’s ability to support clients with:

  • Government investigation readiness
  • Enforcement-driven compliance strategy
  • Healthcare fraud litigation and enforcement matters
  • Whistleblower and False Claims Act case mechanics
  • Administrative law and agency proceedings
  • Medicaid and government program enforcement
  • Reimbursement, payer, licensing, and sanctions disputes
  • Strategic defense positioning when issues escalate

Vivian’s addition reflects Gardner Law’s continued growth as a practical, business-oriented legal resource for companies operating in FDA-regulated industries. Clients increasingly need counsel that can support them across the full product life cycle, from regulatory strategy and compliance program design to investigations, enforcement response, litigation, commercial disputes, privacy, and operational risk.

“Vivian brings real government enforcement experience to Gardner Law, and that perspective is now available to our clients. She understands how enforcement agencies think, how investigations develop, and how companies can better position themselves when scrutiny intensifies. Vivian is a superb addition to our compliance team and to the broader firm.”

Mark Gardner, Founder & Managing Partner

Learn more about Vivian by visiting her profile on our team page.

Vivian will also participate in Gardner Law’s May 14 program, Marking Ten Years: Past, Present, and Future Perspectives in FDA Law, during a discussion on litigation and government enforcement strategy.